Market News

Breaking headlines and analysis across every asset class.

Earnings
AD HOC NEWS • Oct 3, 2026
Travelers Companies schedules results call as stock costs EUR 320.15

Travelers Companies (TRV) has scheduled its third-quarter 2026 earnings call for October 16, 2026, following the release of its results. The company's stock was trading at EUR 320.15 in weekend trading at Lang & Schwarz, a slight increase from its previous close. Investors can access the call and related materials through Travelers' investor website.

Earnings
MarketBeat • Oct 3, 2026
Wells Fargo & Company Initiates Coverage on Charles Schwab (NYSE:SCHW)

Wells Fargo & Company has initiated coverage on Charles Schwab (NYSE:SCHW) with an "equal weight" rating and a $105.00 price target, suggesting an 8.51% upside. This comes amidst broadly positive analyst sentiment, with a consensus "Moderate Buy" rating, although some firms like Piper Sandler have adjusted their price targets. Charles Schwab recently exceeded quarterly earnings expectations, reporting $1.62 EPS against an anticipated $1.56, and revenues of $7.07 billion.

Markets
MarketBeat • Oct 3, 2026
Wells Fargo & Company Begins Coverage on Ares Management (NYSE:ARES)

Wells Fargo & Company initiated coverage on Ares Management (NYSE:ARES) with an "overweight" rating and a $136 price target, indicating a potential upside of 15.56%. This new rating aligns with a "Moderate Buy" consensus among analysts, with an average target price of $156. The report highlights Ares Management's solid Q2 earnings, institutional interest, and positive developments like successful fundraising and strategic investments in renewable energy and telecom infrastructure.

Markets
Investing.com Canada • Oct 3, 2026
Form 4 QUALCOMM Incorporated For: 3 October By Investing.com

This article announces the filing of a Form 4 for QUALCOMM Incorporated on October 3rd. Form 4 filings are typically used to report changes in beneficial ownership of securities by company insiders. The article provides financial market data, including various indices, commodities, and stock performances, relevant to the investment landscape.

Markets
Yahoo Finance • Oct 3, 2026
AbbVie Just Won FDA Approval for a Once-Daily Parkinson's Pill. Here's Why It Matters More Than You Think.

AbbVie recently received FDA approval for Juvmo (tavapadon), a new once-daily Parkinson's pill. This approval is significant as Juvmo is a key asset from AbbVie's $8.7 billion acquisition of Cerevel Therapeutics, designed to strengthen its neuroscience pipeline. The drug offers a new treatment option for Parkinson's patients by selectively activating D1/D5 dopamine receptors and is expected to contribute to AbbVie's growing neuroscience portfolio, with projected annual sales of $1.4 billion by 2

Earnings
MarketBeat • Oct 3, 2026
First Business Financial Services (NASDAQ:FBIZ) Stock Rating Raised to Moderate Buy at Raymond James Financial

Raymond James Financial has upgraded First Business Financial Services (NASDAQ:FBIZ) to a "moderate buy" rating. This upgrade aligns with a consensus "Buy" rating from other analysts, with the stock opening at $70.93, close to its 52-week high. The company recently surpassed earnings and revenue estimates and has seen significant institutional investment, despite some insider selling.

Earnings
MarketBeat • Oct 3, 2026
QCR (NASDAQ:QCRH) Upgraded to Moderate Buy at Raymond James Financial

QCR Holdings (NASDAQ:QCRH) has been upgraded to a "moderate buy" rating by Raymond James Financial, contributing to a largely positive analyst consensus. The company, which recently reported Q2 EPS of $2.19, exceeding estimates, saw its shares open 1.7% higher at $100.95. Institutional investors hold a significant 70.01% stake in QCR.

Earnings
MarketBeat • Oct 3, 2026
Wells Fargo & Company Begins Coverage on StepStone Group (NASDAQ:STEP)

Wells Fargo & Company has initiated coverage on StepStone Group (NASDAQ:STEP) with an "overweight" rating and a $55 price target, suggesting a potential upside of 21.5%. This aligns with a broader "Moderate Buy" consensus from analysts, despite the company's recent quarterly earnings slightly missing expectations. StepStone Group reported $0.48 adjusted earnings per share against an anticipated $0.50, and revenue of $300.6 million compared to an estimated $309.3 million.

Markets
Simply Wall Street • Oct 3, 2026
What The Marex Group (MRX) Run Still Needs To Keep Proving

Marex Group (MRX) has seen a significant stock increase this year, driven by strong Q2 2026 financial results that supported an optimistic outlook on its earnings power. However, the current share price of US$72.75, which is above the Narrative’s Fair Value, assumes that recent earnings strength will be sustained despite potential challenges like mean-reverting market volatility and rising compliance costs. The article suggests investors evaluate whether the current enthusiasm for Marex Group ca

Get Headlines in Your Inbox

One email a day with the market-moving stories you actually need to read.